Ovillis Enzovax 20D

INDICATIONS Ovilis® Enzovax is indicated for the active immunisation of susceptible breeding female sheep as an aid in the prevention of abortion and stillbirth caused by Chlamydophila abortus infection. COMPOSITION Ovilis® Enzovax is a live, attenuated vaccine, containing ≥ 105,0 IFU of Chlamydophila abortus, strain ts 1B, per dose. WARNINGS Withdrawal period: Animals should not be slaughtered for human consumption within 7 days after vaccination. Vaccinate healthy animals only. Do not vaccinate animals less than 4 weeks before mating. Do not vaccinate pregnant animals. Do not vaccinate ewes which are being treated with antibiotics, particularly tetracyclines. Do not administer any other vaccine 14 days before or after vaccination with this product. Do not open and reconstitute the vaccine until ready to start vaccination. After reconstitution the vaccine should be kept cool and must be used within 2 hours. Do not store partially used containers for future use. Vaccinators should be cleaned according to manufacturer’s recommendations prior to reuse. Do not mix Ovilis® Enzovax with other vaccines or medications. Other live vaccines should not be administered within 4 weeks of the administration of Ovilis® Enzovax. DOSAGE AND ADMINISTRATION Ovilis® Enzovax should be reconstituted with Unisolve. Remove approximately 5 mℓ of Unisolve from the vial with a syringe and needle. Inject into the vaccine vial and shake well until the powder plug is fully dissolved. Remove the solution from the vial, re-inject into the diluent vial and shake well. Take care not to generate an aerosol by ensuring that there are no air bubbles in the syringe before re-injecting into the vial. The dose is a single injection of 2 mℓ of reconstituted vaccine by subcutaneous or intramuscular injection. Animals should be revaccinated after 2 years. Ewe lambs, where it is intended to breed from, may be vaccinated from 5 months of age. Shearlings and older ewes should be vaccinated during the 4-month period prior to mating.